跳至主要内容
临床试验/NL-OMON29530
NL-OMON29530尚未招募不适用

A randomized, double blind, cross-over trial to study the effects of addingbezafibrate to standard lipid lowering therapy on postprandial lipids inpatients with familial dysbetalipoproteinemia

niversity Medical Center Utrecht0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Presence of a genetically confirmed apolipoprotein E2 homozygote
  • genotype or an autosomal dominant FD genotype in combination with (at
  • least) one of the following clinical characteristics:

排除标准

  • o Use of any type of fibrate (including but not limited to gemfibrozil,
  • bezafibrate, fenofibrate and ciprofibrate);

研究者

相似试验

已完成
4 期
A randomized, double blind, cross-over trial to study the effects of adding bezafibrate to standard lipid lowering therapy on postprandial lipids in patients with Familial Dysbetalipoproteinemia <br>Familial DysbetalipoproteinemiaFredrickson Type III hyperlipoproteinemia10013317
NL-OMON43954Academisch Medisch Centrum15
已完成
2 期
A randomized, double-blind and cross-over trial to examine effects of continuous administration of intranasal oxytocin on social dysfunction in subjects with autism spectrum disordersAutism spectrum disorders
JPRN-UMIN000007122Department of Neuropsychiatry, Graduate School of Medicine, University of Tokyo20
进行中(未招募)
不适用
A trial comparing the safety and efficacy of insulin degludec and insulin glargine, both with insulin aspart as mealtime insulin in subjects with type 1 diabetesMedDRA version: 17.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 1
EUCTR2012-001930-32-PLovo Nordisk A/S446
进行中(未招募)
不适用
Double blind randomised cross-over trial to assess the value of screening an adult population for hypothyroidism - CROSS OVER RANDOMISED TRIAL OF ADULT HYPOTHROIDISM SCREENING
EUCTR2005-003464-30-GBQueen Mary, University of London
已完成
4 期
A randomized double blind cross-over trial of the effects of low dose and high dose hydrocortisone replacement therapy on cognition, quality of life, metabolic profile and somatosensation in patients with secondary adrenal insufficiencyadrenal insufficiencysecondary adrenal insufficiency10021112
NL-OMON38411niversitair Medisch Centrum Groningen63